FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 70518-4685 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA078152
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20260629
Package count1

External sources

Source: openFDA. Public-domain (CC0).